| Not Yet Recruiting | (TNX-1500) in Kidney Transplant Recipients NCT07204080 | Ayman Al Jurdi, MD | Phase 2 |
| Not Yet Recruiting | ECP-DL Cell Infusion for Induction in Living Donor Kidney (LDK) Transplants NCT07083830 | Northwestern University | Phase 1 |
| Not Yet Recruiting | To Explore the Application Value of Magnetic Resonance Imaging in Noninvasive Quantitative Evaluation of Graft NCT07145944 | Tongji Hospital | — |
| Recruiting | A Trial to Treat Polyomavirus Infections (BKPyV) in Kidney and Simultaneous Kidney Pancreas Transplant Recipie NCT05325008 | The University of Queensland | Phase 3 |
| Active Not Recruiting | Immunological Tolerance in Patients With Mismatched Kidney Transplants NCT05806749 | University of California, Los Angeles | Phase 1 |
| Unknown | Pediatric Kidney Transplantation, Ureteroneocystostomy Techniques NCT05397821 | Radboud University Medical Center | — |
| Not Yet Recruiting | Assessment of QSant™ for Underlying Allograft Rejection NCT05282966 | NephroSant | — |
| Completed | Predicting Prognostic Factors in Kidney Transplantation Using A Machine Learning NCT06394596 | Sung Shin | — |
| Recruiting | Delayed Immunological Tolerance in Patients With Well-functioning Pre-existing HLA-matched Kidney Transplants NCT05525507 | University of California, Los Angeles | Phase 1 |
| Unknown | Prospective Assessment of Rejection in Kidney Transplant (PARK) NCT05715853 | NephroSant | — |
| Enrolling By Invitation | Fingolimod for the Abrogation of Interstitial Fibrosis and Tubular Atrophy Following Kidney Transplantation NCT05285878 | The Methodist Hospital Research Institute | Phase 2 |
| Unknown | Treatment of Early Borderline Lesions in Low Immunological Risk Kidney Transplant Patients (TRAINING) NCT04936282 | Fundación Canaria de Investigación Sanitaria | Phase 4 |
| Completed | Sex Impact on Long-term Outcomes of LDKT NCT06016283 | Erasmus Medical Center | — |
| Completed | BIOtechnology Applied to Renal TRansplantation With IMmunobiogram NCT05816486 | Biohope Scientific Solutions for Human Health, S.L. | — |
| Unknown | Multicenter CTS Pre-and Post-Transplantation Covid-19 Serum Studies NCT04694573 | Heidelberg University | — |
| Recruiting | Efficiency of Everolimus for the Treatment of Kidney Transplanted Patients Presenting a Missing Self-induced N NCT03955172 | Hospices Civils de Lyon | N/A |
| Recruiting | Tacrolimus Pharmacokinetic Subpopulations NCT04526431 | University Hospital, Grenoble | — |
| Recruiting | Home Based Monitoring of Kidney Transplants Utilizing Capillary Microsamples NCT04369612 | Oslo University Hospital | N/A |
| Unknown | The Microbiota in Kidney Donation and Transplantation NCT04388930 | Royal Free Hospital NHS Foundation Trust | — |
| Unknown | Protocol Biopsies in High-risk Renal Transplant Recipients NCT04154267 | Hospital de Clinicas de Porto Alegre | N/A |
| Completed | Using the Speckle Doppler to Quantify Blood Flow in Kidney and Pancreas Grafts NCT04202237 | Manchester University NHS Foundation Trust | — |
| Completed | AlloSure for the Monitoring of Antibody Mediated Processes After Kidney Transplantation NCT04057742 | University of Wisconsin, Madison | — |
| Completed | Cf-DNA Assay During Treatment of Acute Rejection NCT04019353 | University of Minnesota | — |
| Completed | MiRNA in Kidney Transplantation: Association With Kidney Graft Function and Disease Process NCT04413916 | University Medical Centre Ljubljana | — |
| Unknown | Study in Detection cfDNA for the Early-stage Diagnosis of Acute Rejection Post-renal Transplantation NCT03759535 | RenJi Hospital | — |
| Completed | Envarsus on the Effect of Total Tacrolimus Dose/Trough Level Ratio on Renal Function (eGFR) in Kidney Transpla NCT03511560 | Columbia University | Phase 4 |
| Unknown | Prospective Pilot Feasibility Study Comparing Envarsus Once-a-day to Tacrolimus Twice-a-day Immunosuppressive NCT03438773 | California Institute of Renal Research | Phase 1 |
| Completed | A Follow up Study of Patients Treated With Imlifidase Prior to Kidney Transplantation NCT03611621 | Hansa Biopharma AB | — |
| Completed | Comparison of the Cognitive and Motor Effects of Treatment Between an Immediate- and Extended-release Tacrolim NCT03437577 | University of Minnesota | Phase 1 / Phase 2 |
| Active Not Recruiting | Clazakizumab in Highly-HLA Sensitized Patients Awaiting Renal Transplant NCT03380962 | Stanley Jordan, MD | Phase 1 / Phase 2 |
| Unknown | Individualization of the Immunological Risk Based on Selective Biomarkers in Living-donor Renal Recipients NCT03465397 | ORIOL BESTARD | Phase 4 |
| Unknown | Urinary Transglutaminase 2 as a Biomarker for Kidney Allograft Fibrosis NCT03487861 | Asan Medical Center | — |
| Unknown | MRI in Renal Transplantation NCT03705091 | NHS Greater Glasgow and Clyde | — |
| Unknown | AGe-adapted Benefits of Envarsus Versus Twice-daily Tacrolimus ImmunosuppressioN druGs After Kidney Transplant NCT03005236 | University Hospital Birmingham NHS Foundation Trust | Phase 4 |
| Completed | Anti-Angiotensin II Type 1 Receptor Antibodies and Kidney Transplant Outcomes NCT03466775 | Paris Translational Research Center for Organ Transplantation | — |
| Terminated | A Trial of Two Steroid-Free Approaches Toward Mycophenolate Mofetil-Based Monotherapy Immunosuppression NCT00166712 | Northwestern University | Phase 4 |
| Unknown | Long-term Outcomes After Conversion to Belatacept NCT04733131 | Paris Translational Research Center for Organ Transplantation | — |
| Completed | Risk Assessment Tool for Graft Survival in Pediatric Kidney Transplantation NCT05388955 | Radboud University Medical Center | — |